Meropenem Steriscience

Meropenem, the active ingredient in Meropenem Steriscience, is a carbapenem presented as an injectable powder for intravenous use. It treats severe infections caused by susceptible bacteria, including intra‑abdominal, urinary, respiratory, central nervous system and bloodstream infections, in adult and pediatric patients when indicated. GNH USA supplies Meropenem Steriscience as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Meropenem Steriscience is a broad‑spectrum carbapenem antibiotic used to treat serious bacterial infections across several organ systems. - Complicated intra‑abdominal infections: effective against severe intra‑abdominal infections caused by susceptible organisms. - Complicated urinary tract infections: clears resistant urinary pathogens in complicated cases. - Bacterial meningitis: penetrates the cerebrospinal fluid to treat meningitis caused by susceptible bacteria. - Sepsis: provides rapid bactericidal activity in systemic infections. - Pneumonia: treats hospital‑acquired and ventilator‑associated pneumonia caused by resistant strains.

Adverse reactions may occur with meropenem therapy and are categorized by frequency and severity.

Common Side Effects: - Nausea - Diarrhea - Rash - Headache - Elevated liver enzymes - Injection site reactions

Serious or Rare Side Effects: - Seizures, especially in patients with CNS disorders - Clostridioides difficile‑associated colitis - Anaphylaxis or severe hypersensitivity reactions - Severe neutropenia or leukopenia - Renal toxicity or worsening renal function - Severe skin reactions such as Stevens‑Johnson syndrome

Clinicians should consider several precautions when prescribing meropenem. - Renal function: adjust dose in patients with impaired renal function. - Allergy: avoid in patients with known hypersensitivity to carbapenems or other beta‑lactams. - Seizure risk: monitor patients with a history of seizures or central nervous system disorders. - Pregnancy: use only if the potential benefit justifies the potential risk to the fetus. - Antibiotic stewardship: limit use to confirmed infections to reduce resistance development. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Meropenem may interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Valproic acid: may increase risk of seizures. - Phenobarbital: may reduce meropenem effectiveness. - Probenecid: may raise meropenem plasma concentrations. - CNS depressants: additive seizure risk. - Nephrotoxic agents: heightened risk of renal injury.

Moderate Interactions (Monitor Closely): - Aminoglycosides: combined nephrotoxicity. - Loop diuretics: may affect renal clearance. - Warfarin: monitor INR for anticoagulation changes. - Oral contraceptives: possible reduction in contraceptive efficacy. - Immunosuppressants: increased infection risk, monitor closely.